STAT+: What Medicare incentives for AI-based devices mean for tech companies — and hospitals
Reported by STAT News · all stories from statnews.com
Editorial digest
Medicare's financial incentives for artificial intelligence-powered devices hold significant implications for both technology firms and healthcare organizations. These policies shape adoption and innovation.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/13/2026
STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices
An investigation examines Commure and Medicare's AI device incentives.
- Trusted health newsroom9/29/2026
STAT+: The last ‘breakthrough’ devices to get special treatment from Medicare
The article discusses the final 'breakthrough' devices receiving special Medicare treatment.
- Trusted health newsroom9/30/2026
STAT+: What health tech leaders are talking about in Washington policy circles
Leaders in health technology are discussing policy matters in Washington.
- Trusted health newsroom10/28/2026
STAT+: As Epic’s dominance grows, its iron grip is choking innovation in health technology
Epic Systems' expanding market influence is reportedly stifling technological innovation across the healthcare sector.
- Trusted health newsroom10/26/2026
STAT+: HHS relaxes security, transparency rules for health record software used by hospitals
Federal health officials have eased transparency and data protection mandates for hospital electronic record platforms.
- Trusted health newsroom10/22/2026
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
Federal regulators have completed formal guidelines for software applications paired with medications, drawing positive reactions from pharmaceutical manufacturers.